Eye Damaged in Bomb Blast, Regains Vision after Surgery

IMT News Desk
IMT News Desk
· 2 min read
Eye
Dr. Raghu Nagaraju, Senior Consultant, Cornea & Refractive SurgeryDr. Agarwal’s Eye Hospital, Bengaluru along with Patient Abdellah Elham

A 53-year-old female patient from Yemen — Abdellah Elham – nearly-blind due to injuries sustained in a bomb blast in the strife-torn country has regained vision in one eye after treatment. Doctors at Dr. Agarwals Eye Hospital in Bengaluru operated on her successfully, enabling her to see almost perfectly from the damaged eye. This was a huge relief to the patient as she was already blind in her left eye due to a previous surgery conducted when she was young.

Talking about the surgery, Dr. Raghu Nagaraju, General Ophthalmology, Cornea & Refractive Surgery, Dr. Agarwal’s Eye Hospital, Bengaluru, said,“A stone came flying during the bomb blast and hit Abdellah’s right eye with great force, causing severe blunt injury and displacing her eye’s lens from its anatomical position. It was a complex case. The patient in her young age had an eye surgery called radial keratotomy which had weakened her cornea. She was already blind in one eye, while suffering from advanced cataract in the other eye, leading to progressive blurring of vision. When she came to our hospital, she had a vision of only 6/60 in the functioning eye and was barely able to see. Her damaged eye was also suffering from watering, itching and burning sensation. However, the surgery was successful and she has regained vision almost fully in the damaged eye.”

This highly complex surgical procedure was conducted by a team of ophthalmologic surgeons led by Dr. Raghu Nagaraju. The patient’s recovery post-surgery was rapid and her vision in the damaged eye was restored in just two days.

Read Next

Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability
News
May 18, 2026

Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability

Annora Pharma, the formulations subsidiary of Hetero Group, has expanded its collaboration with AltiusHub. The company is deploying AltiusHub’s AI-native serialization, track & trace and regulatory compliance platform across its export operations. The deployment is designed to improve serialization efficiency by up to 45%. It will also strengthen operational visibility across Annora Pharma’s global supply […]
Article by: IMT News Desk
WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation
News
May 18, 2026

WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation

The World Federation of Neurosurgical Societies (WFNS) Innovation & Technology Committee has announced collaboration with Time Medical International Ventures (India) Pvt. Ltd (Time Medical India)., a wholly owned subsidiary of Fischer Medical Ventures Limited, marking a significant milestone in advancing innovation in global neurosurgical care. This marks the first time the Committee has formally partnered […]
Article by: IMT News Desk
National AI Doctors Mission launches in New Delhi: How AI will change Indian healthcare
News
May 18, 2026

National AI Doctors Mission launches in New Delhi: How AI will change Indian healthcare

The National AI Doctors Mission (NAIDM) has been formally launched in New Delhi, marking a major step toward integrating artificial intelligence into everyday clinical practice across India’s public and private healthcare system. The initiative, led by Medical Dialogues in collaboration with the National Medical Forum, aims to make AI “useful and usable” for frontline doctors rather than […]
Article by: IMT News Desk
Gland Pharma rallies on upbeat Q4; profit soars 97% YoY to ₹367 crore
News
May 18, 2026

Gland Pharma rallies on upbeat Q4; profit soars 97% YoY to ₹367 crore

Gland Pharma shares extended gains in the capital markets after the company posted a standout Q4 performance, with consolidated net profit jumping 97% year‑on‑year to ₹367 crore, riding on a sharp improvement in operating leverage and a strong base‑business showing in the US. Revenue for the quarter rose 22% YoY to ₹1,743 crore, while EBITDA surged 48% YoY […]
Article by: IMT News Desk